How is the Aptevo Therapeutics Inc today?

The Aptevo Therapeutics Inc today is trading in the down by -6.67% at 0.28.

What is Aptevo Therapeutics Inc Annual Net Profit?

Aptevo Therapeutics Inc Annual Net Profit fell 38.59% in the last year to $24.13 M. Its sector's average net profit growth for the last fiscal year was -11.13%.

What is Aptevo Therapeutics Inc Price to Earning Ratio?

Aptevo Therapeutics Inc Price to Earning Ratio is -0.09, which is negative.

What is Aptevo Therapeutics Inc Stock Price?

Aptevo Therapeutics Inc Stock Price fell 98.99% and underperformed its sector by 116% in the past year.

What is Aptevo Therapeutics Inc Quarterly Net profit?

Aptevo Therapeutics Inc Quarterly Net profit rose 6.23% YoY to $6.41 M. Its sector's average net profit growth YoY for the quarter was -212.2%.

What is Aptevo Therapeutics Inc Debt to Equity Ratio?

Aptevo Therapeutics Inc Debt to Equity Ratio of 0.97 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Aptevo Therapeutics Inc Return on Equity(ROE)?

Aptevo Therapeutics Inc Return on Equity(ROE) for the last financial year was -284.28%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Aptevo Therapeutics Inc Mutual Fund Holding?

Aptevo Therapeutics Inc Mutual Fund Holding increased by 0.08% in the last quarter to 0.97.

What is Aptevo Therapeutics Inc Institutional Holding?

Aptevo Therapeutics Inc Institutional Holding decreased by 0.46% in the last quarter to 0.46.

Aptevo Therapeutics Inc XNAS: APVO

Aptevo Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Aptevo Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Aptevo Therapeutics Inc
Rating: 0.77408325
Author: Trendlyne DVM scores

about

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which target...

0.28 -0.02 (-6.67%)

99.15% Fall from 52W High

2.0M XNAS Volume

High vol.+loss this week

XNAS 23 May, 2025 4:16 PM (EDT)

Split

Aptevo Therapeutics Inc has split the face value of its shares from $1 to $20 on 27 May 2025. See details

Not Eligible

-

Expensive Valuation

14.8 / 100

Technically Bearish

16.1 / 100

No estimates available

Aptevo Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aptevo Therapeutics Inc FAQ

How is Aptevo Therapeutics Inc today?

Aptevo Therapeutics Inc today is trading in the red, and is down by -6.67% at 0.28.

How has Aptevo Therapeutics Inc performed historically?

Aptevo Therapeutics Inc is currently trading down -6.67% on an intraday basis. In the past week the stock fell -15.15%. stock has been down -91.93% in the past quarter and fell -98.99% in the past year. You can view this in the overview section.